Literature DB >> 32500192

Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.

Hiram Shaish1, Andrew Aukerman2, Rami Vanguri2, Antonino Spinelli3,4, Paul Armenta5, Sachin Jambawalikar6, Jasnit Makkar6, Stuart Bentley-Hibbert6, Armando Del Portillo2, Ravi Kiran7, Lara Monti4, Christiana Bonifacio8, Margarita Kirienko3, Kevin L Gardner2, Lawrence Schwartz6, Deborah Keller7.   

Abstract

OBJECTIVE: To investigate whether pretreatment MRI-based radiomics of locally advanced rectal cancer (LARC) and/or the surrounding mesorectal compartment (MC) can predict pathologic complete response (pCR), neoadjuvant rectal (NAR) score, and tumor regression grade (TRG).
METHODS: One hundred thirty-two consecutive patients with LARC who underwent neoadjuvant chemoradiation and total mesorectal excision (TME) were retrospectively collected from 2 centers in the USA and Italy. The primary tumor and surrounding MC were segmented on the best available T2-weighted sequence (axial, coronal, or sagittal). Three thousand one hundred ninety radiomic features were extracted using a python package. The most salient radiomic features as well as MRI parameter and clinical-based features were selected using recursive feature elimination. A logistic regression classifier was built to distinguish between any 2 binned categories in the considered endpoints: pCR, NAR, and TRG. Repeated k-fold validation was performed and AUCs calculated.
RESULTS: There were 24, 87, and 21 T4, T3, and T2 LARCs, respectively (median age 63 years, 32 to 86). For NAR and TRG, the best classification performance was obtained using both the tumor and MC segmentations. The AUCs for classifying NAR 0 versus 2, pCR, and TRG 0/1 versus 2/3 were 0.66 (95% CI, 0.60-0.71), 0.80 (95% CI, 0.74-0.85), and 0.80 (95% CI, 0.77-0.82), respectively.
CONCLUSION: Radiomics of pretreatment MRIs can predict pCR, TRG, and NAR score in patients with LARC undergoing neoadjuvant treatment and TME with moderate accuracy despite extremely heterogenous image data. Both the tumor and MC contain important prognostic information. KEY POINTS: • Machine learning of rectal cancer on images from the pretreatment MRI can predict important patient outcomes with moderate accuracy. • The tumor and the tissue around it both contain important prognostic information.

Entities:  

Keywords:  Machine learning; Magnetic resonance imaging; Neoadjuvant therapy; Rectal cancer

Mesh:

Year:  2020        PMID: 32500192     DOI: 10.1007/s00330-020-06968-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  1 in total

1.  Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.

Authors:  Angelita Habr-Gama; Rodrigo Oliva Perez; Wladimir Nadalin; Jorge Sabbaga; Ulysses Ribeiro; Afonso Henrique Silva e Sousa; Fábio Guilherme Campos; Desidério Roberto Kiss; Joaquim Gama-Rodrigues
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

  1 in total
  18 in total

Review 1.  Machine Learning Algorithms for Predicting Surgical Outcomes after Colorectal Surgery: A Systematic Review.

Authors:  Mustafa Bektaş; Jurriaan B Tuynman; Jaime Costa Pereira; George L Burchell; Donald L van der Peet
Journal:  World J Surg       Date:  2022-09-15       Impact factor: 3.282

2.  Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models.

Authors:  Iram Shahzadi; Alex Zwanenburg; Annika Lattermann; Annett Linge; Christian Baldus; Jan C Peeken; Stephanie E Combs; Markus Diefenhardt; Claus Rödel; Simon Kirste; Anca-Ligia Grosu; Michael Baumann; Mechthild Krause; Esther G C Troost; Steffen Löck
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

3.  Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer.

Authors:  Xiaoying Lou; Niyun Zhou; Lili Feng; Zhenhui Li; Yuqi Fang; Xinjuan Fan; Yihong Ling; Hailing Liu; Xuan Zou; Jing Wang; Junzhou Huang; Jingping Yun; Jianhua Yao; Yan Huang
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

Review 4.  Artificial Intelligence in Bariatric Surgery: Current Status and Future Perspectives.

Authors:  Mustafa Bektaş; Beata M M Reiber; Jaime Costa Pereira; George L Burchell; Donald L van der Peet
Journal:  Obes Surg       Date:  2022-06-17       Impact factor: 3.479

Review 5.  Rectal MRI radiomics for predicting pathological complete response: Where we are.

Authors:  Joao Miranda; Gary Xia Vern Tan; Maria Clara Fernandes; Onur Yildirim; John A Sims; Jose de Arimateia Batista Araujo-Filho; Felipe Augusto de M Machado; Antonildes N Assuncao-Jr; Cesar Higa Nomura; Natally Horvat
Journal:  Clin Imaging       Date:  2021-11-16       Impact factor: 2.420

6.  Predicting Neoadjuvant Treatment Response in Rectal Cancer Using Machine Learning: Evaluation of MRI-Based Radiomic and Clinical Models.

Authors:  Kent J Peterson; Matthew T Simpson; Melissa K Drezdzon; Aniko Szabo; Robin A Ausman; Andrew S Nencka; Paul M Knechtges; Carrie Y Peterson; Kirk A Ludwig; Timothy J Ridolfi
Journal:  J Gastrointest Surg       Date:  2022-10-21       Impact factor: 3.267

7.  Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development.

Authors:  Giuditta Chiloiro; Davide Cusumano; Paola de Franco; Jacopo Lenkowicz; Luca Boldrini; Davide Carano; Brunella Barbaro; Barbara Corvari; Nicola Dinapoli; Martina Giraffa; Elisa Meldolesi; Riccardo Manfredi; Vincenzo Valentini; Maria Antonietta Gambacorta
Journal:  Radiol Med       Date:  2021-11-01       Impact factor: 3.469

8.  MRI radiomics features of mesorectal fat can predict response to neoadjuvant chemoradiation therapy and tumor recurrence in patients with locally advanced rectal cancer.

Authors:  Vetri Sudar Jayaprakasam; Viktoriya Paroder; Peter Gibbs; Raazi Bajwa; Natalie Gangai; Ramon E Sosa; Iva Petkovska; Jennifer S Golia Pernicka; James Louis Fuqua; David D B Bates; Martin R Weiser; Andrea Cercek; Marc J Gollub
Journal:  Eur Radiol       Date:  2021-07-29       Impact factor: 7.034

9.  MRI-based clinical-radiomics model predicts tumor response before treatment in locally advanced rectal cancer.

Authors:  Andrea Delli Pizzi; Antonio Maria Chiarelli; Piero Chiacchiaretta; Martina d'Annibale; Pierpaolo Croce; Consuelo Rosa; Domenico Mastrodicasa; Stefano Trebeschi; Doenja Marina Johanna Lambregts; Daniele Caposiena; Francesco Lorenzo Serafini; Raffaella Basilico; Giulio Cocco; Pierluigi Di Sebastiano; Sebastiano Cinalli; Antonio Ferretti; Richard Geoffrey Wise; Domenico Genovesi; Regina G H Beets-Tan; Massimo Caulo
Journal:  Sci Rep       Date:  2021-03-08       Impact factor: 4.996

10.  Predicting Treatment Response of Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using Amide Proton Transfer MRI Combined With Diffusion-Weighted Imaging.

Authors:  Weicui Chen; Liting Mao; Ling Li; Qiurong Wei; Shaowei Hu; Yongsong Ye; Jieping Feng; Bo Liu; Xian Liu
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.